Tuberculosis represents the leading global cause of death from an infectious agent. Controlling the tuberculosis epidemic thus represents an urgent global public health priority. Epidemiological modelling suggests that, although drug treatments for tuberculosis continue to improve, WHO timelines to control the spread of the disease require a new vaccine capable of preventing tuberculosis, particularly in adolescents and adults. ‘The status of tuberculosis vaccine development’ reviews the current status of tuberculosis vaccine candidates and outline the diversified vaccine development that are underway.
Please read the full publication: The status of tuberculosis vaccine development